Fresh for you from ESMO 2024:
Decipher test predicts chemotherapy b... - Advanced Prostate...
Decipher test predicts chemotherapy benefits for metastatic prostate cancer patients
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
Max, Interesting article, thanks for sharing. So am I understanding that coming in 2025 a "Decipher" prostate test will be able to help predict which of us guys with Met PCa would benefit most from adding Chemo Docetaxel?
Also what is ESMO 2024? Perhaps a cancer conference ? Thank you
Yup exactly! ESMO 2024 is the European Society for Medical Oncology Congress, which wraps up on Tuesday. I’ve been wanting to keep everyone updated, but I admit I don’t have much "first-hand" information at the moment. Hopefully, there will be plenty of articles to share in the coming days
I see that Decipher requires a biopsy, but probably just one snip.
Not what you're looking for?
You may also like...
New guidelines to prevent skeletal events in metastatic prostate cancer
They are basically discussing denosumab and zoledronic acid in PCa with bone metastasis...
Radiotherapy for Oligometastatic Prostate Cancer
Interesting discussion for those with few mets.
https://www.youtube.com/watch?v=763g5BVjgSg
From:...
Metastatic Prostate Cancer (?)
Hi eveyone,
My husband’s PSA was being followed by our family doctor. He is 62 years old with a...
ESMO 2024: Phase 3 evaluation of transdermal estradiol vs LHRH agonists for androgen suppression
This is very interesting for us all, even if these results are for non metastatic patients!...
Metastatic Prostate Cancer
Just started Zytiga, prednisone and hormone shots for recurrent prostate cancer that has returned...